Melasma: Update on management

Research output: Contribution to journalArticle

Amanda K. Suggs, Selina S. Hamill, Paul Friedman

Melasma is a common, acquired, chronic cutaneous pigment disorder that is often difficult to treat and has a high recurrence rate. The goal of a melasma treatment regimen is to decrease pigment production and increase elimination. Topical tyrosinase inhibitors block melanin synthesis and thereby reduce pigment production. Peels and laser- and light-based devices increase melanin elimination. A multimodality treatment approach targeting both pigment production and elimination is necessary to achieve equilibrium and disease remission. Maintenance treatments are often necessary due to the high recurrence rate. Strict photoprotection is critical to prevent melanogenesis and rebound. Targeting the vasculature via pulsed dye laser or tranexamic acid is another approach to treatment.

Original languageEnglish (US)
Pages (from-to)217-225
Number of pages9
JournalSeminars in cutaneous medicine and surgery
Volume37
Issue number4
DOIs
StatePublished - Dec 1 2018

PMID: 30475935

Altmetrics

Cite this

Standard

Melasma : Update on management. / Suggs, Amanda K.; Hamill, Selina S.; Friedman, Paul.

In: Seminars in cutaneous medicine and surgery, Vol. 37, No. 4, 01.12.2018, p. 217-225.

Research output: Contribution to journalArticle

Harvard

Suggs, AK, Hamill, SS & Friedman, P 2018, 'Melasma: Update on management' Seminars in cutaneous medicine and surgery, vol. 37, no. 4, pp. 217-225. https://doi.org/10.12788/j.sder.2018.049

APA

Suggs, A. K., Hamill, S. S., & Friedman, P. (2018). Melasma: Update on management. Seminars in cutaneous medicine and surgery, 37(4), 217-225. https://doi.org/10.12788/j.sder.2018.049

Vancouver

Suggs AK, Hamill SS, Friedman P. Melasma: Update on management. Seminars in cutaneous medicine and surgery. 2018 Dec 1;37(4):217-225. https://doi.org/10.12788/j.sder.2018.049

Author

Suggs, Amanda K. ; Hamill, Selina S. ; Friedman, Paul. / Melasma : Update on management. In: Seminars in cutaneous medicine and surgery. 2018 ; Vol. 37, No. 4. pp. 217-225.

BibTeX

@article{524cbca701a24bb0b29be8784932a4ea,
title = "Melasma: Update on management",
abstract = "Melasma is a common, acquired, chronic cutaneous pigment disorder that is often difficult to treat and has a high recurrence rate. The goal of a melasma treatment regimen is to decrease pigment production and increase elimination. Topical tyrosinase inhibitors block melanin synthesis and thereby reduce pigment production. Peels and laser- and light-based devices increase melanin elimination. A multimodality treatment approach targeting both pigment production and elimination is necessary to achieve equilibrium and disease remission. Maintenance treatments are often necessary due to the high recurrence rate. Strict photoprotection is critical to prevent melanogenesis and rebound. Targeting the vasculature via pulsed dye laser or tranexamic acid is another approach to treatment.",
author = "Suggs, {Amanda K.} and Hamill, {Selina S.} and Paul Friedman",
year = "2018",
month = "12",
day = "1",
doi = "10.12788/j.sder.2018.049",
language = "English (US)",
volume = "37",
pages = "217--225",
journal = "Seminars in Cutaneous Medicine and Surgery",
issn = "1085-5629",
publisher = "W.B. Saunders Ltd",
number = "4",

}

RIS

TY - JOUR

T1 - Melasma

T2 - Seminars in Cutaneous Medicine and Surgery

AU - Suggs, Amanda K.

AU - Hamill, Selina S.

AU - Friedman, Paul

PY - 2018/12/1

Y1 - 2018/12/1

N2 - Melasma is a common, acquired, chronic cutaneous pigment disorder that is often difficult to treat and has a high recurrence rate. The goal of a melasma treatment regimen is to decrease pigment production and increase elimination. Topical tyrosinase inhibitors block melanin synthesis and thereby reduce pigment production. Peels and laser- and light-based devices increase melanin elimination. A multimodality treatment approach targeting both pigment production and elimination is necessary to achieve equilibrium and disease remission. Maintenance treatments are often necessary due to the high recurrence rate. Strict photoprotection is critical to prevent melanogenesis and rebound. Targeting the vasculature via pulsed dye laser or tranexamic acid is another approach to treatment.

AB - Melasma is a common, acquired, chronic cutaneous pigment disorder that is often difficult to treat and has a high recurrence rate. The goal of a melasma treatment regimen is to decrease pigment production and increase elimination. Topical tyrosinase inhibitors block melanin synthesis and thereby reduce pigment production. Peels and laser- and light-based devices increase melanin elimination. A multimodality treatment approach targeting both pigment production and elimination is necessary to achieve equilibrium and disease remission. Maintenance treatments are often necessary due to the high recurrence rate. Strict photoprotection is critical to prevent melanogenesis and rebound. Targeting the vasculature via pulsed dye laser or tranexamic acid is another approach to treatment.

UR - http://www.scopus.com/inward/record.url?scp=85057180761&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85057180761&partnerID=8YFLogxK

U2 - 10.12788/j.sder.2018.049

DO - 10.12788/j.sder.2018.049

M3 - Article

VL - 37

SP - 217

EP - 225

JO - Seminars in Cutaneous Medicine and Surgery

JF - Seminars in Cutaneous Medicine and Surgery

SN - 1085-5629

IS - 4

ER -

ID: 43271649